Furthermore, dying cell derived HMGB1 activates TLR2/YAP/HIF-1α pathways and induces neighboring CD133− pancreatic cancer cells dedifferentiation, which is an important signaling event underlying tumor relapse following radiotherapy (Fig. 8). Here, HMGB1 is linked to pancreatic neoplasm.